Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma

A. D. Zelenetz, P. Hamlin, T. Kewalramani, J. Yahalom, S. Nimer, C. H. Moskowitz

Research output: Contribution to journal › Article › peer-review

83 Scopus citations

Fingerprint Dive into the research topics of 'Ifosfamide, carboplatin, etoposide (ICE)-based second-line chemotherapy for the management of relapsed and refractory aggressive non-Hodgkin's lymphoma'. Together they form a unique fingerprint.